Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Glucose Monitoring Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Glucose Monitoring Devices is estimated at US$13.9 Billion in 2023 and is projected to reach US$19.2 Billion by 2030, growing at a CAGR of 4.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
Key market drivers and trends include technological leaps such as CGM systems, which provide real-time insights into glucose levels, and the integration of AI into glucose monitoring, AI is increasingly being incorporated into glucose monitoring systems to enhance the predictive accuracy of devices.
These systems can analyze data over time to predict future trends in glucose levels, enabling preemptive management of potential issues. Artificial Intelligence (AI) is reshaping many aspects of healthcare, including diabetes management Government policies promoting better screening and monitoring, alongside patient education emphasizing self-monitoring, further drive adoption. Wearable glucose monitors that seamlessly integrate with everyday life are gaining traction. These devices continuously track glucose levels and offer the convenience of not having to perform multiple daily finger-prick tests.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Self-Monitoring Devices segment, which is expected to reach US$11.3 Billion by 2030 with a CAGR of a 3.8%. The Continuous Blood Glucose Monitoring Devices segment is also set to grow at 6.1% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $3.7 Billion in 2023, and China, forecasted to grow at an impressive 7.8% CAGR to reach $4.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Diabetes Care, Inc., ACON Laboratories, Inc., AgaMatrix, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 268 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $13.9 Billion |
| Forecasted Market Value (USD) by 2030 | $19.2 Billion |
| Compound Annual Growth Rate | 4.7% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- Global Economic Update
- Glucose Monitoring Devices - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Rising Incidence of Diabetes Globally Strengthens Business Case for Glucose Monitoring Devices
- Growing Awareness of the Benefits of Regular Glucose Monitoring Drives Adoption Across Various Demographics
- Growth in Home Healthcare Services Generates Demand for User-Friendly Glucose Monitoring Solutions
- Innovations in Non-Invasive Glucose Monitoring Technology Spurs Market Growth
- Expansion of Telemedicine and Remote Monitoring Sustains Growth in Glucose Monitoring Devices Market
- Integration of Artificial Intelligence in Glucose Monitoring Enhances Data Accuracy and Insights
- Technological Developments in Smartphone-Connected Glucose Monitors Propel Market Expansion
- Emphasis on Preventive Healthcare Drives Adoption of Continuous Glucose Monitoring Solutions
- Adoption of Glucose Monitoring in Pediatric Care Expands Addressable Market Opportunity
- Increasing Use of Glucose Monitoring in Fitness and Wellness Accelerates Demand for Multifunctional Devices
FOCUS ON SELECT PLAYERS (Total 32 Featured)
- Abbott Diabetes Care, Inc.
- ACON Laboratories, Inc.
- AgaMatrix, Inc.
- Alive Technologies Pty. Ltd.
- ARKRAY, Inc.
- Ascensia Diabetes Care Holdings AG
- B. Braun Melsungen AG
- Beurer GmbH
- Dexcom, Inc.
- GlySens Inc.
- LifeScan, Inc.
- Medtronic plc
- Nova Biomedical Corporation
- Omron Healthcare Co., Ltd.
- Roche Diagnostics
- Senseonics Holdings, Inc.
- Terumo Corporation
- Trividia Health, Inc.
- Ypsomed Holding AG
For more information about this report visit https://www.researchandmarkets.com/r/xqqaul
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
